What does Rhythm Pharmaceuticals, Inc. do?
Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company that develops peptide therapeutics for rare genetic metabolic disorders. As of March 2025, it reported net sales of $33 million and a net loss of $49 million, with a market cap of approximately $3.94 billion.
Overview: Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing peptide therapeutics for rare genetic deficiencies that lead to life-threatening metabolic disorders, operating within the Pharmaceuticals & Biotechnology industry and classified as a small-cap company.Financial Snapshot:
Most recent Net Sales: 33 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -49 Million (Quarterly Results - Mar 2025)
Market cap: USD 3,942.62 Million (Small Cap)
Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -3.20
Return on Equity: -926.82%
Price to Book: 208.09
Contact Details:
Address: 222 Berkeley St Fl 12, BOSTON MA: 02116-3733
Tel: ['1 857 2644280', '1 212 3621200']
Fax: 1 857 2644299
Website: http://www.rhythmtx.com
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
